Prevalence and Resolution of Lupus Anticoagulant in Children

REFERENCES

1. ↵
   1. Ciaudo M,
   2. Horellou MH,
   3. Audouin J,
   4. De Carbonnieres C,
   5. Conard J,
   6. Samama M

   Lupus anticoagulant associated with primary malignant lymphoplasmacytic lymphoma of the spleen: a report of four patients. Am J Hematol. 1991 12; 38 4: 271- 276. pmid:1746535

   OpenUrlPubMedWeb of Science
2. ↵
   1. Shi W,
   2. Krilis SA,
   3. Chong BH,
   4. Gordon S,
   5. Chesterman CN

   Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust N Z J Med. 1990 6; 20 3: 231- 236. pmid:2115326

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Conley CL,
   2. Hartmann RC

   A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest. 1952; 31: 621- 622.

   OpenUrl
4. ↵
   1. Bowie EJ,
   2. Thompson JH Jr.,
   3. Pascuzzi CA,
   4. Owen CA Jr.

   Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med. 1963 9; 62: 416- 430. pmid:14061973

   OpenUrlPubMedWeb of Science
5. ↵
   1. Brandt JT,
   2. Triplett DA,
   3. Alving B,
   4. Scharrer I

   Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost. 1995 10; 74 4: 1185- 1190. pmid:8560433

   OpenUrlPubMedWeb of Science
6. 1. Greaves M,
   2. Cohen H,
   3. MacHin SJ,
   4. Mackie I

   Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol. 2000 6; 109 4: 704- 715. pmid:10929019

   OpenUrlCrossRefPubMedWeb of Science
7. 1. Exner T,
   2. Triplett DA,
   3. Taberner D,
   4. Machin SJ

   Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants. Thromb Haemost. 1991 3 4; 65 3: 320- 322. pmid:1904657

   OpenUrlPubMedWeb of Science
8. Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force. J Clin Pathol. 1991 11; 44 11: 885- 889.

   OpenUrlFREE Full Text
9. ↵
   1. Tripodi A

   Testing for lupus anticoagulants: all that a clinician should know. Lupus. 2009 4; 18 4: 291- 298. pmid:19276296

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    1. Cuadrado MJ,
    2. Hughes GR

    Hughes (antiphospholipid) syndrome. Clinical features. Rheum Dis Clin North Am. 2001 8; 27 3: 507- 524, v. pmid:11534257

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Vivaldi P,
    2. Rossetti G,
    3. Galli M,
    4. Finazzi G

    Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature. Haematologica. 1997 May-Jun; 82 3: 345- 347. pmid:9234588

    OpenUrlAbstract/FREE Full Text
12. ↵
    1. Bernini JC,
    2. Buchanan GR,
    3. Ashcraft J

    Hypoprothrombinemia and severe hemorrhage associated with a lupus anticoagulant. J Pediatr. 1993 12; 123 6: 937- 939. pmid:8229526

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Mikayis S,
    2. Lockshin MD,
    3. Atsumi T,
    4. et al.

    International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 2; 4 2: 295- 306. pmid:16420554

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    1. Singh AK,
    2. Rao KP,
    3. Kizer J,
    4. Lazarchick J

    Lupus anticoagulants in children. Ann Clin Lab Sci. 1988 Sep-Oct; 18 5: 384- 387. pmid:3140708

    OpenUrlAbstract/FREE Full Text
15. ↵
    1. Male C,
    2. Lechner K,
    3. Eichinger S,
    4. et al.

    Clinical significance of lupus anticoagulants in children. J Pediatr. 1999 2; 134 2: 199- 205. pmid:9931530

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    1. Casais P,
    2. Meschengieser SS,
    3. Gennari LC,
    4. et al.

    Morbidity of lupus anticoagulants in children: a single institution experience. Thromb Res. 2004; 114 4: 245- 249. pmid:15381387

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Manco-Johnson MJ,
    2. Nuss R

    Lupus anticoagulant in children with thrombosis. Am J Hematol. 1995 4; 48 4: 240- 243. pmid:7717372

    OpenUrlPubMedWeb of Science
18. ↵
    1. Giordano P,
    2. Tesse R,
    3. Lassandro G,
    4. et al.

    Clinical and laboratory characteristics of children positive for antiphospholipid antibodies. Blood Transfus. 2012 7; 10 3: 296- 301. pmid:22244004

    OpenUrlPubMed
19. ↵
    1. Avcin T,
    2. Cimaz R,
    3. Silverman ED,
    4. et al.

    Pediatric antiphopholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Pediatrics. 2008 11; 122 5: e1100- e1107. pmid:18955411

    OpenUrlAbstract/FREE Full Text
20. ↵
    1. Follea G,
    2. Coiffier B,
    3. Viale JP,
    4. Dechavanne M

    Antiprothrombinase and factor II deficiency in a non SLE patient. Thromb Haemost. 1981 10; 46 3: 670. pmid:7314062

    OpenUrlPubMed
21. ↵
    1. Bajaj SP,
    2. Rapaport SI,
    3. Fierer DS,
    4. Herbst KD,
    5. Schwartz DB

    A mechanism for the hypoprothrombinemia of the acquired hypothrombinemia-lupus anticoagulant syndrome. Blood. 1983 4; 61 4: 684- 692. pmid:6403077

    OpenUrlAbstract/FREE Full Text
22. ↵
    1. Jameil NA,
    2. Tyagi P,
    3. Shenefy AA

    Incidence of anticardiolipin antibodies and lupus anticoagulant factor among women experiencing unexplained recurrent abortion and intrauterine fetal death. Int J Clin Exp Pathol. 2015 3 1; 8 3: 3204- 3209. pmid:26045841

    OpenUrlPubMed